Low-density lipoprotein apheresis using the Liposorber system: features of the system and clinical benefits.
- 1 February 1998
- journal article
- Published by Wiley in Therapeutic Apheresis
- Vol. 2 (1), 25-30
- https://doi.org/10.1111/j.1744-9987.1998.tb00069.x
Abstract
No abstract availableKeywords
This publication has 31 references indexed in Scilit:
- Decreased susceptibility of low-density lipoproteins to in-vitro oxidation after dextran-sulfate LDL-apheresis treatmentAtherosclerosis, 1996
- LDL Apheresis Reduces the Susceptibility of LDL to in Vitro oxidation in a Diabetic Patient With Hemodialysis TreatmentDiabetes Care, 1996
- Development of Selective Low-Density Lipoprotein (LDL) Apheresis System: Immobilized Polyanion as LDL-Specific Adsorption for LDL Apheresis SystemArtificial Organs, 1996
- Removal of LDL from plasma by adsorption reduces adhesion molecules on mononuclear cells in patients with arteriosclerotic obliteranceAtherosclerosis, 1995
- Different effects of two methods of low‐density lipoprotein apheresis on the coagulation and fibrinolytic systems3Journal of Internal Medicine, 1993
- The pathogenesis of atherosclerosis: a perspective for the 1990sNature, 1993
- LDL-apheresis with dextran sulphate and anaphylactoid reactions to ACE inhibitorsThe Lancet, 1993
- ACE inhibitors and LDL-apheresis with dextran sulphate adsorptionThe Lancet, 1992
- Treatment of refractory familial hypercholesterolemia by low-density lipoprotein apheresis using an automated dextran sulfate cellulose adsorption systemThe American Journal of Cardiology, 1992
- Anaphylactoid reactions, LDL apheresis with dextran sulphate, and ACE inhibitorsThe Lancet, 1992